Is Artivion Inc (NYSE: AORT) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

AORT belongs to the Healthcare sector of the NYSE while operating in the Medical Devices industry. The current market capitalization of Artivion Inc is $1.05B. A total of 0.63 million shares were traded on the day, compared to an average of 361.06K shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, AORT has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.

In the most recent transaction, Horton Amy sold 3,323 shares of AORT for 27.31 per share on Feb 24 ’25. After the transaction, the VP, Chief Accounting Officer now owns 131,141 company shares. In a previous transaction on Feb 24 ’25, Mackin James P sold 42,156 shares at 27.31 per share. AORT shares that President & CEO owns now total 663,882.

Among the insiders who sold shares, Holloway Jean F disposed of 5,335 shares on Feb 24 ’25 at a per-share price of $27.31. This resulted in the SVP, General Counsel holding 149,799 shares of AORT after the transaction. In another insider transaction, Davis John E sold 6,457 shares at $27.31 per share on Feb 24 ’25. Company shares held by the Chief Commercial Officer now total 160,631.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for AORT in the last 3 months, the mean price target is $32.33 with high estimates of $35.00 and low estimates of $30.00. In terms of 52-week highs and lows, AORT has a high of $32.33 and a low of $18.38.

As of this writing, AORT has an earnings estimate of $0.05 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of $0.12 per share and a lower estimate of -$0.01.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. AORT’s latest balance sheet shows that the firm has $55.01M in Cash & Short Term Investments as of fiscal 2021. There were $362.04M in debt and $44.95M in liabilities at the time. Its Book Value Per Share was $6.58, while its Total Shareholder’s Equity was $300.73M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AORT is Buy with a score of 4.83.

Most Popular

Related Posts